Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 12, 2021 at 05:15 pm EST
Actinium Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 0.233 million. Net loss was USD 6.42 million compared to USD 5.54 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.36 a year ago.
For the nine months, revenue was USD 1.12 million. Net loss was USD 16.76 million compared to USD 15.84 million a year ago. Basic loss per share from continuing operations was USD 0.84 compared to USD 1.46 a year ago.